<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03099408</url>
  </required_header>
  <id_info>
    <org_study_id>2016PUSZH001</org_study_id>
    <nct_id>NCT03099408</nct_id>
  </id_info>
  <brief_title>Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis</brief_title>
  <official_title>A Pilot Study of Efficacy and Safety of Oral Metronidazole Versus Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent the Recurrence of Bacterial Vaginosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Shenzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Shenzhen Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are trying to determine if Oral Metronidazole with Lactobacillus Vaginal Suppositories is
      better than Oral Metronidazole in Preventing the Recurrence of Bacterial Vaginosis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bacterial vaginosis (BV) is the most prevalent cause of symptomatic vaginal discharge in the
      U.S. and has been associated with complications including preterm delivery of infants, pelvic
      inflammatory disease (PID), urinary tract infections (UTI) and acquisition/transmission of
      sexually transmitted diseases (STDs) including human immunodeficiency virus (HIV).

      Control of BV has been advocated as a means of decreasing the prevalence of these
      complications. However, the etiology of BV remains unknown and the current treatment regimens
      are inadequate in terms of initial cure and recurrence rates.

      Based on currently national guidelines by using oral metronidazole 400 BID for 7 days, a high
      recurrence rate of BV were reported.

      We hypothesize that the Oral Metronidazole with Lactobacillus Vaginal Suppositories is better
      than Oral Metronidazole in Preventing the Recurrence of Bacterial Vaginosis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cure rate of BV</measure>
    <time_frame>4 weeks</time_frame>
    <description>Nugent score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence of BV</measure>
    <time_frame>12 weeks</time_frame>
    <description>Nugent score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of BV</measure>
    <time_frame>24 weeks</time_frame>
    <description>Nugent score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <condition>Recurrence</condition>
  <arm_group>
    <arm_group_label>Metronidazole Oral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metronidazole Oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Metronidazole&quot; and &quot;Lactobacillus&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&quot;Metronidazole&quot; and &quot;Lactobacillus&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole Oral</intervention_name>
    <description>Oral metronidazole 400 mg BID for 7 days at first month.</description>
    <arm_group_label>Metronidazole Oral</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>&quot;Metronidazole&quot; and &quot;Lactobacillus&quot;</intervention_name>
    <description>Oral metronidazole metronidazole 400 mg BID for 7 days at first month and Lactobacillus vaginal suppositories for 10 days at first month,second month and third month.</description>
    <arm_group_label>&quot;Metronidazole&quot; and &quot;Lactobacillus&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women be at least 18 years of age

          -  Have symptoms of vaginal odor and or/discharge

          -  Meet the clinical (Amsel) criteria for BV

          -  Willing to participate in research

        Exclusion Criteria:

          -  Presence of another vaginal infection or STD

          -  Allergy to metronidazole

          -  Pregnant or nursing

          -  Use of oral or intravaginal antibiotics within the past 2 weeks

          -  HIV or other chronic disease

          -  Inability to keep return appointments

          -  Contraindications for Lactobacillus Vaginal Suppositories（those without sexual
             history）
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shangrong Fan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Shenzhen Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salvatore Giovanni Vitale, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Human Pathology in Adulthood and Childhood, Gaetano Barresi, University of Messina (Italy)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ping Liu, M.D.</last_name>
    <phone>86-755-83923333</phone>
    <phone_ext>5505</phone_ext>
    <email>253783006@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yiheng Liang, M.D.</last_name>
    <phone>86-755-83923333</phone>
    <phone_ext>5502</phone_ext>
    <email>13510331823@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept Obstetrics and Gynecology</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518036</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ping Liu, M.D.</last_name>
      <phone>86-755-83923333</phone>
      <phone_ext>5502</phone_ext>
      <email>253783006@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Yiheng Liang, M.D.</last_name>
      <phone>86-755-83923333</phone>
      <phone_ext>5505</phone_ext>
      <email>13510331823@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Shangrong Fan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Shenzhen Hospital</investigator_affiliation>
    <investigator_full_name>Shangrong Fan</investigator_full_name>
    <investigator_title>Profesor</investigator_title>
  </responsible_party>
  <keyword>Recurrence</keyword>
  <keyword>Lactobacillus Vaginal Suppositories</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

